Suppr超能文献

伪狂犬病病毒胸苷激酶阴性缺失突变体的减毒特性

Attenuated properties of thymidine kinase-negative deletion mutant of pseudorabies virus.

作者信息

Kit S, Kit M, Pirtle E C

出版信息

Am J Vet Res. 1985 Jun;46(6):1359-67.

PMID:2992322
Abstract

A thymidine kinase (TK)-negative (TK-) deletion mutant of the Bucharest (BUK) strain of pseudorabies virus (PRV) was isolated. The mutant, designated as PRV (BUK d13), did not revert to TK-positive (TK+), even when propagated in medium that selected for TK+ viruses. The mutant also replicated equally well at 39.1 C and 34.5 C, and was easily distinguished from other PRV strains by molecular hybridization experiments, restriction nuclease fingerprints, and plaque autoradiography or other assays for the TK phenotype. The PRV (BUK d13) had greatly reduced virulence for mice and rabbits, compared with parental TK+ strains, PRV (BUK-5) and PRV (BUK-5A-R1), and provided mice with solid protection against the TK+ BUK and Aujeszky strains of PRV. Experiments were done in 5- to 6-week-old pigs to assess the safety and efficacy of PRV (BUK d13) in the natural host. In one experiment, pigs were vaccinated IM with 7.5 X 10(8) plaque-forming units of TK- PRV (BUK d13), and were then challenge exposed intranasally (IN) with 4.3 X 10(8) TCID50 of virulent PRV [Indiana-Funkhauser (IND-F)]. Vaccinated pigs did not have clinical signs of illness after vaccination or after challenge exposure. One nonvaccinated control pig died on postchallenge day 4; a 2nd nonvaccinated control pig became moribund, but eventually recovered. Pigs developed virus-neutralizing antibodies after vaccination, and had a secondary immunologic response after challenge exposure; however, PRV was not isolated from the tonsils or trigeminal ganglia of vaccinated pigs at postchallenge exposure day 11.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

分离出了伪狂犬病病毒(PRV)布加勒斯特(BUK)株的胸苷激酶(TK)阴性(TK-)缺失突变体。该突变体命名为PRV(BUK d13),即使在选择TK+病毒的培养基中传代培养,也不会回复为TK阳性(TK+)。该突变体在39.1℃和34.5℃下的复制能力相同,通过分子杂交实验、限制性核酸酶指纹图谱、噬斑放射自显影或其他TK表型检测方法,很容易与其他PRV株区分开来。与亲本TK+株PRV(BUK-5)和PRV(BUK-5A-R1)相比,PRV(BUK d13)对小鼠和兔子的毒力大大降低,并为小鼠提供了针对PRV的TK+ BUK和奥耶斯基株的可靠保护。在5至6周龄的猪身上进行了实验,以评估PRV(BUK d13)在天然宿主中的安全性和有效性。在一项实验中,给猪肌肉注射7.5×10⁸噬斑形成单位的TK- PRV(BUK d13),然后经鼻内(IN)接种4.3×10⁸半数组织培养感染剂量(TCID50)的强毒PRV [印第安纳-芬克豪泽(IND-F)]。接种疫苗的猪在接种疫苗后或攻击暴露后没有出现疾病的临床症状。一只未接种疫苗的对照猪在攻击后第4天死亡;第二只未接种疫苗的对照猪濒死,但最终康复。猪在接种疫苗后产生了病毒中和抗体,并在攻击暴露后产生了二次免疫反应;然而,在攻击暴露后第11天,未从接种疫苗的猪的扁桃体或三叉神经节中分离出PRV。(摘要截短至250字)

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验